Psychological factors at early stage of treatment as predictors of receiving chemotherapy at the end of life

ConclusionAnxiety, depression, and worse psychological quality of life at early stage of treatment may be associated with the receipt of IV chemotherapy at the EOL. Further research is needed to examine how these factors might influence decision‐making about the discontinuation of chemotherapy at the EOL. Copyright © 2015 John Wiley & Sons, Ltd.

Source: Psycho-Oncology - May 8, 2015 Category: Cancer & Oncology Authors: Daisuke Fujisawa, Jennifer S. Temel, Lara Traeger, Joseph A. Greer, Inga T. Lennes, Masaru Mimura, William F. Pirl Tags: Paper Source Type: research